News
-
-
PRESS RELEASE
Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
Immunic, Inc. (Nasdaq: IMUX) to release Q3 financial results and corporate update on Nov 7, 2024. Webcast at 8:00 am ET. Company developing therapies for inflammatory and autoimmune diseases. Visit www.imux.com for more info -
PRESS RELEASE
Fullintel Hosts Webinar on Measurement Strategies to Mitigate Today's PR Crises
Fullintel announces upcoming webinar on Crisis Measurement Strategies to Mitigate & Avoid Crises in alignment with AMEC Measurement Month, offering cutting-edge crisis management strategies by industry experts. Join Angela Dwyer and James Rubec on November 13, 2024, at 1:00 p.m. EST -
-
-
-
-
-
PRESS RELEASE
EQS-Adhoc: INDUS Holding AG: INDUS lowers its EBIT forecast for the financial year 2024 due to non-cash expenses from the annual impairment test
INDUS Holding AG adjusts its EBIT forecast for 2024 due to non-cash expenses from an impairment test, lowering it to EUR 115-125 million from EUR 125-145 million -